Status:

UNKNOWN

Impact of Exogenous Estrogens on Cotisol Levels During Synacthen Stimulation

Lead Sponsor:

Rigshospitalet, Denmark

Conditions:

Adrenal Insufficiency

Hypogonadism Female

Eligibility:

FEMALE

18-50 years

Phase:

NA

Brief Summary

The aim is to investigate impact of exogenous estrogens on cotisol Levels during synacthen stimulation in female hypogonal patients on estrogen substitution. Both patients with and withour adrenal ins...

Detailed Description

The aim is to investigate impact of exogenous estrogens on cotisol levels during synacthen stimulation in female hypogonal patients on estrogen substitution. Both patients with and without adrenal ins...

Eligibility Criteria

Inclusion

  • Hypogonadism
  • Treatment with estrogen substitution

Exclusion

  • Other formulations of glucocorticoid than oral hydrocortisone
  • Pregnancy
  • BMI \> 35

Key Trial Info

Start Date :

January 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2023

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT05302726

Start Date

January 1 2022

End Date

June 1 2023

Last Update

March 31 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Mikkel Mr Andreassen

Copenhagen, Denmark, 2100

Impact of Exogenous Estrogens on Cotisol Levels During Synacthen Stimulation | DecenTrialz